BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35249063)

  • 21. [Long-Term Survival of a Gastric Neuroendocrine Carcinoma Patient with Extra-Regional Lymph Node Metastases].
    Ozawa Y; Chiba N; Hikita K; Okihara M; Sano T; Tomita K; Takano K; Kawachi S
    Gan To Kagaku Ryoho; 2017 Apr; 44(4):333-336. PubMed ID: 28428516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
    Lu Y; Xi H; Xie T; Qiu Z; Wang X; Wei B; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):143-148. PubMed ID: 30799536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is lymph node dissection for neuroendocrine carcinoma of the stomach effective as it is for adenocarcinoma?
    Yamagata Y; Yoshikawa T; Ishizu K; Kamiya A; Wada T; Hayashi T; Otsuki S; Katai H
    Eur J Surg Oncol; 2021 Aug; 47(8):2004-2009. PubMed ID: 33408057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A Case of Esophagogastric Junction Adenocarcinoma with Multiple Esophageal Intramural Metastases].
    Akamaru Y; Wada N; Wada R; Munakata K; Takiuchi D; Morimoto O; Ota H; Shibata K; Ohashi H
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2126-2128. PubMed ID: 30692306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A Case of cStage Ⅲ Esophagogastric Junction Adenocarcinoma That Showed pCR to Preoperative Chemotherapy Containing SOX].
    Kobayashi T; Kosuga T; Kubota T; Okamoto K; Shoda K; Konishi H; Shiozaki A; Fujiwara H; Arita T; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Otsuji E
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2369-2371. PubMed ID: 30692467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of the effect of lymph node dissection performed by Ivor-Lewis or left-sided thoracic esophagogastrectomy for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction].
    Duan XF; Gong L; Ma MQ; Yue J; Tang P; Shang XB; Jiang HJ; Yu ZT
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):190-194. PubMed ID: 28316217
    [No Abstract]   [Full Text] [Related]  

  • 27. Nivolumab exerts therapeutic effects against metastatic lesions from early gastric adenocarcinoma with a small proportion of neuroendocrine carcinoma after gastrectomy: a case report.
    Sawayama H; Komohara Y; Hirao H; Sakata K; Takata N; Yoshinaka I; Harada K; Baba H
    Clin J Gastroenterol; 2020 Oct; 13(5):759-765. PubMed ID: 32592148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathological Complete Response and Long-Term Survival of a Gastric Neuroendocrine Carcinoma Patient Treated by Neoadjuvant Chemotherapy].
    Takahashi K; Musha H; Suzuki T; Kamio Y; Hachiya O; Motoi F
    Gan To Kagaku Ryoho; 2022 Feb; 49(2):205-207. PubMed ID: 35249062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgery and clinicopathological features of gastric adenocarcinoma involving the esophago-gastric junction.
    Koufuji K; Shirouzu K; Aoyagi K; Yano S; Miyagi M; Imaizumi T; Takeda J
    Kurume Med J; 2005; 52(3):73-9. PubMed ID: 16422172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer.
    Haverkamp L; Seesing MF; Ruurda JP; Boone J; V Hillegersberg R
    Dis Esophagus; 2017 Jan; 30(1):1-7. PubMed ID: 27001442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical study on two reconstruction methods of proximal gastrectomy and piggyback jejunal interposition for Siewert Ⅱ or Ⅲ adenocarcinoma of esophagogastric junction].
    Xu N; Dong JH; Zhang WH; Tao K; Huang QX; Li ZG; Zong L
    Zhonghua Wai Ke Za Zhi; 2019 Feb; 57(2):114-118. PubMed ID: 30704214
    [No Abstract]   [Full Text] [Related]  

  • 32. [Surgical treatment strategies for Siewert type II adenocarcinoma of the esophagogastric junction].
    Yan Q; Lyu ZJ; Zheng JB; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):1008-1012. PubMed ID: 33054000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case showing a complete response by weekly paclitaxel associated with severe empyema and mediastinal abscess caused by reduction of a recurrent lung metastatic tumor originating from adenocarcinoma of the esophagogastric junction after primary operation].
    Kimura A; Hiramatsu K; Sakuragawa T; Ito T; Otsuji H; Tsuchiya T; Hara T; Maeda T; Tanaka H; Machiki Y; Hosoya J; Kojima T; Kato K
    Gan To Kagaku Ryoho; 2010 Feb; 37(2):303-5. PubMed ID: 20154490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gastric Neuroendocrine Carcinoma(NEC)Treated with CDDP plus CPT-11 Chemotherapy].
    Ono K; Takehana T; Yamamoto K; Kawai S; Nagase M
    Gan To Kagaku Ryoho; 2019 Jan; 46(1):65-69. PubMed ID: 30765645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curative resection by splenectomy for solitary splenic metastasis from early gastric cancer: a case report and literature review.
    Yoshizawa J; Kubo N; Ishizone S; Karasawa F; Nakayama A
    BMC Cancer; 2017 Jun; 17(1):436. PubMed ID: 28637437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tuberous sclerosis patient with neuroendocrine carcinoma of the esophagogastric junction: A case report.
    Ishida N; Miyazu T; Tamura S; Suzuki S; Tani S; Yamade M; Iwaizumi M; Osawa S; Hamaya Y; Shinmura K; Sugimura H; Miura K; Furuta T; Sugimoto K
    World J Gastroenterol; 2020 Dec; 26(45):7263-7271. PubMed ID: 33362382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case Report: A Rare Case of Esophagogastric Junctional Squamous Cell Carcinoma After the Successful Treatment of Neuroendocrine Carcinoma: Clonal Tumor Evolution Revealed by Genetic Analysis.
    Sato H; Saito T; Horii H; Kajiura M; Kikuchi N; Takada N; Taguchi K; Yoshida M; Hasegawa M; Taguchi H; Yoshida Y; Ando K; Fujiya M; Omori Y; Hank T; Liss AS; Gala MK; Makita Y; Ono Y; Mizukami Y; Okumura T
    Front Genet; 2021; 12():608324. PubMed ID: 34616420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option.
    Hu C; Zhu HT; Xu ZY; Yu JF; Du YA; Huang L; Yu PF; Wang LJ; Cheng XD
    J Int Med Res; 2019 Jan; 47(1):398-410. PubMed ID: 30296865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Two Cases of Esophagogastric Junction Cancer after Subtotal Stomach-Preserving Pancreaticoduodenectomy].
    Furukawa H; Kawabata R; Miyagaki H; Yoshikawa Y; Sueda T; Matsumura T; Koga C; Wakasugi M; Tei M; Tsujie M; Hasegawa J
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):1824-1826. PubMed ID: 33468841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction.
    Sugita S; Kinoshita T; Kaito A; Watanabe M; Sunagawa H
    Surg Endosc; 2018 Jan; 32(1):383-390. PubMed ID: 28656339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.